top of page
Dr. Bevilacqua an invited panelist for FDA workshop “Understanding the Development of Non-Traditional Therapies for Bacterial Infections”
SILVER SPRING, MD - AUGUST 20, 2019 - Dr. Michael Bevilacqua, Amicrobe’s founder and CEO, was an invited expert panelist at the FDA workshop entitled "Understanding the Development of Non-Traditional Therapies for Bacterial Infection." The workshop focused on discussion of the landscape and important regulatory challenges associated with various areas of non-traditional therapies.
bottom of page